What is Besivance primarily indicated for?

Besivance, which contains the active ingredient besifloxacin, is an antibiotic that is primarily indicated for the treatment of eye infections. It is specifically approved for the treatment of bacterial conjunctivitis. This information aligns with the function of Besivance as it targets bacterial pathogens affecting the eyes, leading to improvements in symptoms associated with conjunctivitis.

The other choices involve areas where Besivance is not indicated. Skin infections typically require different formulations of antibiotics or topical medications, while serious infections and respiratory infections involve conditions that generally necessitate a broader spectrum of systemic antibiotics rather than a localized eye drop medication. Thus, choosing eye infections as the primary indication reflects the specific therapeutic use of Besivance in targeting bacteria associated with ocular conditions.